Home Other Building Blocks 37073-18-0
37073-18-0,MFCD09045405
Catalog No.:AA003F08

37073-18-0 | 2-(Methylsulfonamido)aniline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$34.00   $24.00
- +
1g
97%
in stock  
$50.00   $35.00
- +
5g
96%
in stock  
$135.00   $95.00
- +
10g
96%
in stock  
$253.00   $177.00
- +
25g
96%
in stock  
$613.00   $430.00
- +
100g
96%
in stock  
$2,175.00   $1,523.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003F08
Chemical Name:
2-(Methylsulfonamido)aniline
CAS Number:
37073-18-0
Molecular Formula:
C7H10N2O2S
Molecular Weight:
186.2315
MDL Number:
MFCD09045405
SMILES:
Nc1ccccc1NS(=O)(=O)C
NSC Number:
48642
Properties
Properties
 
BP:
340.1°C at 760 mmHg  
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
232  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
0.2  

Downstream Synthesis Route
37073-18-0   
C7H9BrN2O2S 

[1]Ruble,J.Craig;Wakefield,BrianD.;Kamilar,GreggM.;Marotti,KeithR.;Melchior,Earline;Sweeney,MichaelT.;Zurenko,GaryE.;Romero,DonnaL.[BioorganicandMedicinalChemistryLetters,2007,vol.17,#14,p.4040-4043]

37073-18-0   
C21H19BrClN3O5S2 

[1]Ruble,J.Craig;Wakefield,BrianD.;Kamilar,GreggM.;Marotti,KeithR.;Melchior,Earline;Sweeney,MichaelT.;Zurenko,GaryE.;Romero,DonnaL.[BioorganicandMedicinalChemistryLetters,2007,vol.17,#14,p.4040-4043]

[1]Locationinpatent:experimentalpartFu,Shaomin;Jiang,Huanfeng;Deng,Yuanfu;Zeng,Wei[AdvancedSynthesisandCatalysis,2011,vol.353,#14-15,p.2795-2804]

[2]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-WO2004/33440,2004,A1Locationinpatent:Page313

[3]CurrentPatentAssignee:MERCK&COINC;LIGANDPHARMACEUTICALSINC-US2004/147559,2004,A1Locationinpatent:Page173

[4]CurrentPatentAssignee:MERCK&COINC;LIGANDPHARMACEUTICALSINC-US2004/106794,2004,A1Locationinpatent:Page174

[5]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-WO2005/68460,2005,A1Locationinpatent:Page/Pagecolumn277

[6]CurrentPatentAssignee:SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-CN106432246,2017,ALocationinpatent:Paragraph0453;0849;0850;0851;0852

[7]Saha,Satyajit;Moorthy,JaruguNarasimha[TetrahedronLetters,2010,vol.51,#6,p.912-916]

[1]Choe,Hyeonjeong;Jeon,ByeongUk;Jung,MyoungEun;Jeon,Moon-Kook;Shin,Inji;Cho,ByoungChul;Choi,Gildon;Chae,ChongHak;Lee,Kwangho[BulletinoftheKoreanChemicalSociety,2017,vol.38,#11,p.1353-1357]

[2]CurrentPatentAssignee:KOREARESEARCHINSTITUTEOFCHEMICALTECHNOLOGY-EP3640246,2020,A1Locationinpatent:Paragraph0091;0092;0093

[3]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2008/51547,2008,A1Locationinpatent:Page/Pagecolumn535

[4]Song,Zilan;Yang,Yanhong;Liu,Zhiqing;Peng,Xia;Guo,Junfeng;Yang,Xinying;Wu,Kui;Ai,Jing;Ding,Jian;Geng,Meiyu;Zhang,Ao[JournalofMedicinalChemistry,2015,vol.58,#1,p.197-211]

[5]Ott,GregoryR.;Cheng,Mangeng;Learn,KeithS.;Wagner,Jason;Gingrich,DianeE.;Lisko,JosephG.;Curry,Matthew;Mesaros,EugenF.;Ghose,ArupK.;Quail,MatthewR.;Wan,Weihua;Lu,Lihui;Dobrzanski,Pawel;Albom,MarkS.;Angeles,ThelmaS.;Wells-Knecht,Kevin;Huang,Zeqi;Aimone,LisaD.;Bruckheimer,Elizabeth;Anderson,Nathan;Friedman,Jay;Fernandez,SandraV.;Ator,MarkA.;Ruggeri,BruceA.;Dorsey,BruceD.[JournalofMedicinalChemistry,2016,vol.59,#16,p.7478-7496]

[6]Zhang,Hualin;Xie,Ruliang;Ai-Furas,Hawaa;Li,Yupeng;Wu,Qingxia;Li,Jian;Xu,Fang;Xu,Tianfeng[ACSMedicinalChemistryLetters,2022,vol.13,#2,p.278-283]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:37073-18-0 Molecular Formula|37073-18-0 MDL|37073-18-0 SMILES|37073-18-0 2-(Methylsulfonamido)aniline